Adaptive Biotechnologies Corp (ADPT) earnings · rev $142.4M
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
This ADPT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
When the next ADPT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for ADPT. We will not invent a beat or miss.
Not investment advice. Full ADPT research stays on the stock page; the tape stays on the quote page.
Not investment advice.